Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Yaqing Zhang

Matched on ORCID iD 0000-0002-9185-4364; OpenAlex author ID A5037667722; NIH RePORTER profile ID 10840179. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
2
Labs led
1
Collaborators
34
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 grant · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 5 papers, 1 grant

Papers 8

  1. A stromal PAI1-tPA axis orchestrates immunosuppression in pancreatic cancer. Co-author DOI 10.1126/sciadv.aea6734↗
  2. Wilms Tumor 1-Expressing Stromal Cells Promote Pancreatic Cancer Progression. Co-author DOI 10.1158/0008-5472.can-25-1014↗
  3. Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization. Co-author DOI 10.1158/2159-8290.cd-25-0377↗
  4. Asynchronous Evolution of Epithelium and Stroma Differentiates Precursor Lesions from Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-25-2001↗
  5. Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-25-1300↗
  6. Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-23-0037↗
  7. WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer. Co-author DOI 10.1084/jem.20220503↗
  8. Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma. Co-author DOI 10.1016/j.jcmgh.2020.05.004↗

Grants 2

  1. Metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer. R01CA290780↗
  2. Targeting the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer R50CA232985↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marina Pasca di Magliano · 8 shared papers, 2020–2026 · strength 1.58
  2. Bin Zheng · 1 shared grant, 2026 · strength 1.26
  3. Eileen S. Carpenter · 6 shared papers, 2023–2026 · strength 1.21
  4. Filip Bednar · 6 shared papers, 2020–2026 · strength 1.14
  5. Timothy L. Frankel · 4 shared papers, 2026 · strength 0.86
  6. Padma Kadiyala · 4 shared papers, 2023–2026 · strength 0.79
  7. Katelyn L. Donahue · 4 shared papers, 2023–2026 · strength 0.76
  8. Jiaqi Shi · 3 shared papers, 2026 · strength 0.72
  9. Ahmed M. Elhossiny · 3 shared papers, 2026 · strength 0.63
  10. Wei Yan · 3 shared papers, 2024–2026 · strength 0.61
  11. Rosa Elena Menjivar · 3 shared papers, 2023–2026 · strength 0.54
  12. Brian D. Griffith · 2 shared papers, 2026 · strength 0.43
  13. Emily L. Lasse Opsahl · 2 shared papers, 2026 · strength 0.43
  14. Costas Andreas Lyssiotis · 2 shared papers, 2026 · strength 0.40
  15. Wenting Du · 2 shared papers, 2023–2024 · strength 0.34
  16. Kyoung Eun Lee · 1 shared paper, 2026 · strength 0.28
  17. Ashley M. Mello · 1 shared paper, 2026 · strength 0.28
  18. Tenzin Ngodup · 1 shared paper, 2026 · strength 0.28
  19. Sean Matthew Hannifin · 1 shared paper, 2026 · strength 0.28
  20. Allison Bischoff · 1 shared paper, 2026 · strength 0.24
  21. Holly Attebury · 1 shared paper, 2026 · strength 0.22
  22. Elana Judith Fertig · 1 shared paper, 2026 · strength 0.21
  23. Julianne M. Szczepanski · 1 shared paper, 2026 · strength 0.21
  24. Mariana T. Ruckert · 1 shared paper, 2026 · strength 0.21
  25. Anirban Maitra · 1 shared paper, 2026 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.